Finance

Lists
ORX:STO
Orexo AB
5,11 SEK
-1,92%
(-0,100) 1D
26 հոկ, 17:29:37 GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ORX...
Open
5,01 SEK
High
5,19 SEK
Low
4,90 SEK
Mkt. cap
179,50 մլն
Avg. vol.
123,54 հզր
Volume
41,78 հզր
P/E ratio
0,22
52-wk high
36,00 SEK
52-wk low
4,90 SEK
EPS
23,61 SEK
Shares outstanding
35,13 մլն
No. of employees
55
Open
5,01 SEK
High
5,19 SEK
Low
4,90 SEK
Mkt. cap
179,50 մլն
Avg. vol.
123,54 հզր
Volume
41,78 հզր
P/E ratio
0,22
52-wk high
36,00 SEK
52-wk low
4,90 SEK
EPS
23,61 SEK
Shares outstanding
35,13 մլն
No. of employees
55
News stories
From web sources and news partners
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
Sector-
Websiteorexo.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
3,30 մլն
5,00 մլն
3,50 մլն
800,00 հզր
Cost of goods sold
2,60 մլն
500,00 հզր
100,00 հզր
100,00 հզր
Cost of revenue
2,60 մլն
500,00 հզր
100,00 հզր
100,00 հզր
Research and development expenses
55,60 մլն
50,10 մլն
53,40 մլն
54,10 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28,00 մլն
37,40 մլն
58,20 մլն
15,90 մլն
Operating expense
80,70 մլն
80,20 մլն
106,50 մլն
62,20 մլն
Total operating expenses
83,30 մլն
80,70 մլն
106,60 մլն
62,30 մլն
Operating income
-80,00 մլն
-75,70 մլն
-103,10 մլն
-61,50 մլն
Other non operating income
-200,00 հզր
-100,00 հզր
-300,00 հզր
100,00 հզր
EBT including unusual items
-115,50 մլն
-104,20 մլն
-102,30 մլն
-95,80 մլն
EBT excluding unusual items
-93,50 մլն
-104,50 մլն
-103,00 մլն
-61,20 մլն
Income tax expense
100,00 հզր
1,00 մլն
200,00 հզր
22,10 մլն
Effective tax rate
-0,09%
-0,96%
-0,20%
-23,07%
Other operating expenses
-2,90 մլն
-7,30 մլն
-5,10 մլն
-7,80 մլն
Net income
724,80 մլն
-133,90 մլն
-100,40 մլն
-96,40 մլն
Net profit margin
21 963,64%
-2 678,00%
-2 868,57%
-12 050,00%
Earnings per share
-
-
-2,53
-
Interest and investment income
600,00 հզր
4,40 մլն
2,00 մլն
1,30 մլն
Interest expense
-12,20 մլն
-32,90 մլն
-
-
Net interest expenses
-11,60 մլն
-28,50 մլն
2,00 մլն
1,30 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-46,80 մլն
-66,90 մլն
-94,90 մլն
-53,40 մլն
Gain or loss from assets sale
-
-
-
300,00 հզր
Upcoming events
AI content may include mistakes. Learn more
Google Apps